Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Aug 06, 2019	Report of unscheduled material events or corporate event	8-K	View HTML 0001346302-19-000028.pdf 0001346302-19-000028.rtf 0001346302-19-000028.xls
Aug 06, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001346302-19-000029.pdf 0001346302-19-000029.rtf 0001346302-19-000029.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Aug 06, 2019	Simplified registration form	S-3	View HTML 0001193125-19-214231.pdf 0001193125-19-214231.rtf 0001193125-19-214231.xls
Aug 08, 2019	UPLOAD	UPLOAD	View HTML 0000000000-19-012227.pdf 0000000000-19-012227.rtf
Aug 19, 2019	CORRESP	CORRESP	View HTML 0001193125-19-224505.pdf 0001193125-19-224505.rtf 0001193125-19-224505.xls
Aug 21, 2019	EFFECT	EFFECT	View HTML 9999999995-19-001941.pdf 9999999995-19-001941.rtf 9999999995-19-001941.xls
Sep 10, 2019	Report of unscheduled material events or corporate event	8-K	View HTML 0001346302-19-000033.pdf 0001346302-19-000033.rtf 0001346302-19-000033.xls
Sep 12, 2019	Amendment to a previously filed 4	4/A	View HTML 0000899243-19-023467.pdf 0000899243-19-023467.rtf 0000899243-19-023467.xls
Oct 01, 2019	Report of unscheduled material events or corporate event	8-K	View HTML 0001346302-19-000035.pdf 0001346302-19-000035.rtf 0001346302-19-000035.xls
Oct 02, 2019	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0000899243-19-024729.pdf 0000899243-19-024729.rtf 0000899243-19-024729.xls

Data provided by Kaleidoscope.